• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的危险因素及可能的运动前期标志物的关系。

Relation of risk factors and putative premotor markers for Parkinson's disease.

机构信息

Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Hoppe-Seyler Str. 3, 72076, Tübingen, Germany.

出版信息

J Neural Transm (Vienna). 2011 Apr;118(4):579-85. doi: 10.1007/s00702-010-0553-x. Epub 2011 Jan 6.

DOI:10.1007/s00702-010-0553-x
PMID:21210286
Abstract

As both risk and premotor markers are increasingly discussed to play a key role in the pre-diagnostic phase of Parkinson's disease (PD) the aim of this study was to determine the relation between the risk factors hyperechogenicity of the substantia nigra (SN+) and/or positive family history of PD (faPD+) and putative premotor markers for PD. In a cross-sectional analysis of data of the PRIPS cohort, 1,149 volunteers older than 50 years free of PD were included. In addition to the risk factors SN+ and faPD+, olfactory dysfunction was tested using the Sniffin' sticks test and motor examination was performed. History of depression and constipation was evaluated by a semi-structured interview. Of all 1,149 individuals, 880 had none of the risk markers (76.6%), 143 persons (12.4%) had SN+, 84 (7.3%) were classified as faPD+ and 42 (3.7%) persons had both risk factors. Volunteers with SN+ showed olfactory dysfunction and mild motor impairment (p ≤ 0.001) more often. Depression was more prominent in individuals having two risk factors (p = 0.05). An accumulation of premotor markers was seen in the SN+ group with or without concomitant faPD+, but not in persons with faPD+ only. The profile of premotor markers seems to differ in participants having SN+ and/or faPD+, with SN+ showing the overall highest association with most premotor markers, which implies that SN+ might be a strong indicator for a neurodegenerative process.

摘要

由于风险和运动前标志物越来越被认为在帕金森病 (PD) 的预诊断阶段发挥关键作用,本研究旨在确定黑质超声回声增高 (SN+) 和/或 PD 阳性家族史 (faPD+) 等风险因素与 PD 的潜在运动前标志物之间的关系。在 PRIPS 队列的横断面数据分析中,纳入了 1149 名年龄大于 50 岁且无 PD 的志愿者。除了风险因素 SN+和 faPD+外,还使用 Sniffin' sticks 测试检测嗅觉功能障碍,进行运动检查。通过半结构化访谈评估抑郁和便秘史。在所有 1149 名个体中,880 名无任何风险标志物(76.6%),143 名(12.4%)有 SN+,84 名(7.3%)被归类为 faPD+,42 名(3.7%)有两个风险因素。有 SN+的志愿者更常出现嗅觉功能障碍和轻度运动障碍(p≤0.001)。有两个风险因素的个体中抑郁更为明显(p=0.05)。在有或没有并发 faPD+的 SN+组中观察到运动前标志物的累积,但在只有 faPD+的个体中没有。具有 SN+和/或 faPD+的参与者的运动前标志物特征似乎不同,SN+与大多数运动前标志物的总体关联最高,这意味着 SN+可能是神经退行性过程的强烈指标。

相似文献

1
Relation of risk factors and putative premotor markers for Parkinson's disease.帕金森病的危险因素及可能的运动前期标志物的关系。
J Neural Transm (Vienna). 2011 Apr;118(4):579-85. doi: 10.1007/s00702-010-0553-x. Epub 2011 Jan 6.
2
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.帕金森病运动前期标志物的评估:运动前期标志物研究。
Neuroepidemiology. 2013;41(3-4):174-82. doi: 10.1159/000353560. Epub 2013 Sep 17.
3
Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.联合中脑超声、嗅觉和运动功能评估在早期帕金森病鉴别诊断中的价值。
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):441-7. doi: 10.1136/jnnp-2011-301719. Epub 2012 Feb 22.
4
Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD.经颅超声(TCS)在帕金森病(PD)和特发性震颤(ET)中与 PD 的潜在运动前症状的关系。
Arch Gerontol Geriatr. 2012 May-Jun;54(3):e436-9. doi: 10.1016/j.archger.2012.01.001. Epub 2012 Jan 25.
5
Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.嗅觉与黑质高回声联合评估对帕金森病的诊断价值
Neurologia. 2015 Oct;30(8):496-501. doi: 10.1016/j.nrl.2014.03.010. Epub 2014 May 17.
6
Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.PD 的运动前期迹象与 TCS 评估的老年人群中 SN 过度回声有关。
Neurobiol Aging. 2011 Sep;32(9):1599-606. doi: 10.1016/j.neurobiolaging.2009.10.004. Epub 2009 Nov 7.
7
Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.中脑高回声、嗅觉减退、轻度帕金森病征象与 10 年内帕金森病发病风险:一项前瞻性基于人群的研究。
Parkinsonism Relat Disord. 2020 Jan;70:51-54. doi: 10.1016/j.parkreldis.2019.12.008. Epub 2019 Dec 11.
8
Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.黑质回声增强与老年人的运动表现和嗅觉有关。
Mov Disord. 2010 Jul 30;25(10):1464-9. doi: 10.1002/mds.23114.
9
Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.横断面研究表明,帕金森病的阳性家族史和男性性别是黑质高回声的流行病学危险因素。
J Neural Transm (Vienna). 2007 Sep;114(9):1167-71. doi: 10.1007/s00702-007-0725-5. Epub 2007 Apr 20.
10
Transcranial sonography in the premotor diagnosis of Parkinson's disease.经颅超声在帕金森病运动前期诊断中的应用。
Int Rev Neurobiol. 2010;90:93-106. doi: 10.1016/S0074-7742(10)90007-X.

引用本文的文献

1
Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice.在α-突触核蛋白过表达小鼠中模拟帕金森病相关症状。
Brain Behav. 2022 Jul;12(7):e2628. doi: 10.1002/brb3.2628. Epub 2022 Jun 1.
2
Depressive disorders in the elderly and dementia: An update.老年人的抑郁症与痴呆症:最新进展
Dement Neuropsychol. 2020 Jan-Mar;14(1):1-6. doi: 10.1590/1980-57642020dn14-010001.
3
Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study.早期帕金森病中的自主神经功能障碍:英国帕金森病追踪研究结果

本文引用的文献

1
Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.黑质回声增强与老年人的运动表现和嗅觉有关。
Mov Disord. 2010 Jul 30;25(10):1464-9. doi: 10.1002/mds.23114.
2
Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.PD 的运动前期迹象与 TCS 评估的老年人群中 SN 过度回声有关。
Neurobiol Aging. 2011 Sep;32(9):1599-606. doi: 10.1016/j.neurobiolaging.2009.10.004. Epub 2009 Nov 7.
3
Use of antidepressants and the risk of Parkinson's disease: a prospective study.
Mov Disord Clin Pract. 2016 Nov 24;4(4):509-516. doi: 10.1002/mdc3.12454. eCollection 2017 Jul-Aug.
4
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?帕金森病的诊断生物标志物一览:我们在哪里?
J Neural Transm (Vienna). 2018 Oct;125(10):1417-1432. doi: 10.1007/s00702-018-1910-4. Epub 2018 Aug 25.
5
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.神经功能正常受试者结肠中的α-突触核蛋白与帕金森病的运动前标记物
Neurol Sci. 2017 Jan;38(1):171-179. doi: 10.1007/s10072-016-2745-0. Epub 2016 Nov 1.
6
Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.琥珀酸布可洛尔,一种非他汀类降胆固醇药物,可预防帕金森病实验模型中的运动前症状和黑质纹状体神经退行性变。
Mol Neurobiol. 2017 Mar;54(2):1513-1530. doi: 10.1007/s12035-016-9747-z. Epub 2016 Feb 6.
7
Neuropathobiology of non-motor symptoms in Parkinson disease.帕金森病非运动症状的神经病理生物学
J Neural Transm (Vienna). 2015 Oct;122(10):1429-40. doi: 10.1007/s00702-015-1405-5. Epub 2015 May 15.
8
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.GBA 突变阳性队列中帕金森病前驱临床标志物的演变
JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.
9
Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.重度抑郁症后患帕金森病的预测:一项十年随访研究。
J Neural Transm (Vienna). 2015 Jun;122(6):789-97. doi: 10.1007/s00702-014-1313-0. Epub 2014 Sep 14.
抗抑郁药的使用与帕金森病风险:一项前瞻性研究。
J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):671-4. doi: 10.1136/jnnp.2008.152983.
4
Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations.一个携带纯合和杂合PINK1突变的大家族中的经颅超声检查结果。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1071-4. doi: 10.1136/jnnp.2007.142174. Epub 2008 May 9.
5
Biomarkers for the early detection of Parkinson's and Alzheimer's disease.用于帕金森病和阿尔茨海默病早期检测的生物标志物。
Neurodegener Dis. 2008;5(3-4):133-6. doi: 10.1159/000113682. Epub 2008 Mar 6.
6
Update on the genetics of Parkinson's disease.帕金森病遗传学的最新进展。
Mov Disord. 2007 Sep;22 Suppl 17:S343-50. doi: 10.1002/mds.21676.
7
Association of olfactory dysfunction with risk for future Parkinson's disease.嗅觉功能障碍与未来帕金森病风险的关联。
Ann Neurol. 2008 Feb;63(2):167-73. doi: 10.1002/ana.21291.
8
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease.帕金森病患者亲属患帕金森病及嗅觉障碍的风险因素。
Mov Disord. 2007 Nov 15;22(15):2249-55. doi: 10.1002/mds.21707.
9
Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.帕金森病样中脑超声异常在抑郁症中很常见。
Brain. 2007 Jul;130(Pt 7):1799-807. doi: 10.1093/brain/awm017. Epub 2007 Feb 28.
10
Transcranial brain parenchyma sonography in movement disorders: state of the art.运动障碍中的经颅脑实质超声检查:现状
Ultrasound Med Biol. 2007 Jan;33(1):15-25. doi: 10.1016/j.ultrasmedbio.2006.07.021.